Celldex Therapeutics (CLDX) Q1 2016 Earnings

23FebConfirmed
Q2 2015
Q3 2015
Q4 2015
Q1 2016
-5.49
-5.26
-5.03
-4.8

Details

Expected EPS
-5.02
Actual EPS
-4.95
Surprise EPS
0.07
Surprise Percent
+1.39%

Description

Celldex Therapeutics (CLDX) has reported earnings of -4.95 per share for Q1 2016.

0 Comments

Share your thoughts